KPIs & Operating Metrics(New)
Breakdown Of AssetsEmployee StatisticsFixed Assets, Net BreakdownGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome (Loss) Before Income TaxLicense Revenue By Category AnnualOpex As A % Of Total Revenue %OPEX SegregationProduct Revenue By CategoryProduct Revenue By Category AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Trx By Product
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Gross Profit (2016 - 2023)

Historic Gross Profit for TherapeuticsMD (TXMD) over the last 13 years, with Q4 2023 value amounting to $502000.0.

  • TherapeuticsMD's Gross Profit fell 9926.79% to $502000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year decrease of 9843.21%. This contributed to the annual value of $1.3 million for FY2023, which is 9810.11% down from last year.
  • As of Q4 2023, TherapeuticsMD's Gross Profit stood at $502000.0, which was down 9926.79% from -$53000.0 recorded in Q3 2023.
  • In the past 5 years, TherapeuticsMD's Gross Profit ranged from a high of $68.6 million in Q4 2022 and a low of -$53000.0 during Q3 2023
  • Over the past 5 years, TherapeuticsMD's median Gross Profit value was $13.5 million (recorded in 2019), while the average stood at $13.6 million.
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 70271.83% in 2019, then plummeted by 9926.79% in 2023.
  • TherapeuticsMD's Gross Profit (Quarter) stood at $13.0 million in 2019, then surged by 30.52% to $17.0 million in 2020, then dropped by 17.98% to $13.9 million in 2021, then soared by 391.83% to $68.6 million in 2022, then plummeted by 99.27% to $502000.0 in 2023.
  • Its Gross Profit stands at $502000.0 for Q4 2023, versus -$53000.0 for Q3 2023 and $437000.0 for Q2 2023.